NDC 60687-455

Abiraterone Acetate

Abiraterone

Abiraterone Acetate is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by American Health Packaging. The primary component is Abiraterone Acetate.

Product ID60687-455_9376d9a3-6c02-b2fa-e053-2995a90a1dd5
NDC60687-455
Product TypeHuman Prescription Drug
Proprietary NameAbiraterone Acetate
Generic NameAbiraterone
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2019-10-01
Marketing CategoryANDA / ANDA
Application NumberANDA208327
Labeler NameAmerican Health Packaging
Substance NameABIRATERONE ACETATE
Active Ingredient Strength250 mg/1
Pharm ClassesCytochrome P450 17A1 Inhibitors [MoA],Cytochrome P450 17A1 Inhibitor [EPC],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 60687-455-21

30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-455-21) > 1 TABLET in 1 BLISTER PACK (60687-455-11)
Marketing Start Date2019-10-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 60687-455-11 [60687045511]

Abiraterone Acetate TABLET
Marketing CategoryANDA
Application NumberANDA208327
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-10-01

NDC 60687-455-21 [60687045521]

Abiraterone Acetate TABLET
Marketing CategoryANDA
Application NumberANDA208327
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-10-01

Drug Details

Active Ingredients

IngredientStrength
ABIRATERONE ACETATE250 mg/1

OpenFDA Data

SPL SET ID:b5a22401-2a46-45d0-86ac-1fc6ecfb9a21
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1100075
  • Pharmacological Class

    • Cytochrome P450 17A1 Inhibitors [MoA]
    • Cytochrome P450 17A1 Inhibitor [EPC]
    • Cytochrome P450 2D6 Inhibitors [MoA]
    • Cytochrome P450 2C8 Inhibitors [MoA]
    • Cytochrome P450 17A1 Inhibitors [MoA]
    • Cytochrome P450 17A1 Inhibitor [EPC]
    • Cytochrome P450 2D6 Inhibitors [MoA]
    • Cytochrome P450 2C8 Inhibitors [MoA]

    NDC Crossover Matching brand name "Abiraterone Acetate" or generic name "Abiraterone"

    NDCBrand NameGeneric Name
    0093-1125Abiraterone AcetateAbiraterone Acetate
    0378-6920Abiraterone Acetateabiraterone acetate
    0378-6921Abiraterone Acetateabiraterone acetate
    0378-6924Abiraterone Acetateabiraterone acetate
    0904-6948Abiraterone AcetateAbiraterone Acetate
    16714-963Abiraterone AcetateAbiraterone Acetate
    42291-024Abiraterone AcetateAbiraterone
    42291-073ABIRATERONE ACETATEABIRATERONE
    42292-057Abiraterone Acetateabiraterone acetate
    43598-358Abiraterone AcetateAbiraterone Acetate
    69238-1165Abiraterone AcetateAbiraterone Acetate
    51407-181Abiraterone AcetateAbiraterone Acetate
    57894-199Abiraterone acetateAbiraterone acetate
    57894-155Abiraterone acetateAbiraterone acetate
    60505-4327Abiraterone AcetateAbiraterone Acetate
    64679-021Abiraterone acetateAbiraterone acetate
    64980-418Abiraterone acetateAbiraterone acetate
    60687-455Abiraterone AcetateAbiraterone Acetate
    72606-566Abiraterone acetateAbiraterone acetate
    68462-135abiraterone acetateabiraterone acetate
    0143-9597AbirateroneAbiraterone acetate
    47335-401YONSAabiraterone acetate

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.